High Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD Cohort

BACKGROUND & AIMS: Occasional risk of serious liver dysfunction and autoimmune hepatitis during atorvastatin therapy has been reported. We compared the risk of hepatotoxicity in atorvastatin relative to simvastatin treatment. METHODS: The UK GPRD identified patients with a first prescription for...

Descripción completa

Detalles Bibliográficos
Autores principales: Clarke, Alan T., Johnson, Paul C. D., Hall, Gillian C., Ford, Ian, Mills, Peter R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794178/
https://www.ncbi.nlm.nih.gov/pubmed/26983033
http://dx.doi.org/10.1371/journal.pone.0151587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794178/
https://www.ncbi.nlm.nih.gov/pubmed/26983033
http://dx.doi.org/10.1371/journal.pone.0151587

Ejemplares similares